通过血清精度和药物动力学控制来设计下一代迷幻疗法
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ACS medicinal chemistry letters
|December 17, 2025
概括
新的迷幻类药物正在开发中,以准5-HT2A受体,提供更安全,更短效的治疗方法. 这些创新旨在提高精神疾病的可预测性.
科学领域:
- 心理药理学和药物化学
- 神经科学是一个神经科学.
背景情况:
- 像DMT和精神素这样的迷幻化合物显示出对精神疾病的治疗潜力.
- 目前的迷幻疗法面临着难以预测的持续时间和不良影响的挑战.
- 需要新的药物设计来优化临床使用的迷幻药物.
研究的目的:
- 审查关于新型迷幻类别的近期专利.
- 要突出在5-HT2A受体调节方面的创新.
- 讨论创造更安全,更短效的迷幻药物的进展.
主要方法:
- 对近期关于迷幻药类同类药物的专利文献进行分析.
- 化学修饰的探索,包括前药物设计和化.
- 对DMT和西洛辛衍生物的结构-活性关系研究.
主要成果:
- 专利揭示了具有优化的5-HT2A受体结合的新类型.
- 创新侧重于减少不良影响和控制作用的持续时间.
- 精制的支架提供可调的药理动力学和药理动力学配置文件.
结论:
- 这些新的迷幻类型代表了精神病医学的重大进步.
- 优化的化合物有望提高安全性,可预测性和临床工作流集成.
- 未来的迷幻疗法可能会提供更多可控和有效的治疗选择.
相关概念视频
CNS Stimulants: Psychedelic Agents
637
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
637
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
What is Genetic Engineering?
79.5K
Overview
79.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


